The African Cancer Atlas: Advancing Precision Oncology Through Genomic Diversity
Fill out the form below and we'll send your colleague an invitation to the "The African Cancer Atlas: Advancing Precision Oncology Through Genomic Diversity" event.
Global cancer genomics datasets remain heavily skewed toward European populations, limiting the discovery of clinically relevant variants, biomarkers, and therapeutic targets. As cancer incidence rises worldwide, closing this gap is becoming increasingly urgent for both research and precision oncology.
In this webinar, our expert speakers will show how large-scale cancer genome sequencing—across nine African countries—is uncovering population-specific variants, structural alterations, and epigenetic signals. Using nanopore sequencing, these studies reveal biological insights that may influence biomarker discovery, drug development, and the future of inclusive precision cancer care.
Attend this webinar to:
- Understand how long-read sequencing enables more accurate detection of structural variants, somatic copy number alterations, and epigenetic signals in cancer genomes
- See how population-scale cancer genomics is uncovering novel driver mutations and mutational signatures that may inform biomarker discovery and therapeutic research
- Learn how integrated genomic profiling is being implemented in pediatric leukemia care in Ghana—and what this reveals about scaling precision oncology in diverse healthcare settings
Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.
